Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR 314.101 Filing an NDA and receiving an ANDA.
21 CFR 314.101 Filing an NDA and receiving an ANDA., “Filing an NDA and receiving an ANDA”, is a CFR section of 21 CFR Part 314, Subpart D—FDA Action on Applications and Abbreviated Applications; in force.
https://ontology.bommaritollc.com/id/01a0f094-c4cd-75f0-b892-95a5845f7ce4
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR 314.101 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Filing an NDA and receiving an ANDAen |
| schema:url | |
| skos:prefLabel | 21 CFR 314.101 Filing an NDA and receiving an ANDA.en |
Related
Cited by (5)eli:cites
- 21 CFR 312.84 Risk-benefit analysis in review of marketing applications for drugs to treat life-threatening and severely-debilitating illnesses.
- 21 CFR 314.125 Refusal to approve an NDA.
- 21 CFR 314.3 Definitions.
- 21 CFR 314.52 Notice of certification of invalidity, unenforceability, or noninfringement of a patent.
- 21 CFR 314.60 Amendments to an unapproved NDA, supplement, or resubmission.